Feedback / Questions
ApTOLL - aptaTargets
glenzocimab (ACT 017) - Acticor Biotech
http://www.ncbi.nlm.nih.gov/pubmed/39582054
Bernhard Nieswandt; Guido Stoll; Michael K Schuhmann
Nov 25, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next